JP6966206B2 - 更年期症状又は骨粗鬆症改善用組成物 - Google Patents

更年期症状又は骨粗鬆症改善用組成物 Download PDF

Info

Publication number: JP6966206B2
Authority: JP; Japan
Prior art keywords: extract; group; composition; menopausal symptoms; chenpi
Prior art date: 2016-04-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

JP2017057171A

Other languages

English (en)

Japanese (ja)

Other versions

JP2017197519A (ja

Inventor

ヨン・ジュン・イ

ホ・ソン・チョウ

ウォン・キョン・イ

スン・ラン・ソン

サン・ファ・イ

Original Assignee

エルジーハウスホールドアンドヘルスケアリミテッド

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2016-04-25

Filing date

2017-03-23

Publication date

2021-11-10

2017-03-23 Application filed by エルジーハウスホールドアンドヘルスケアリミテッド filed Critical エルジーハウスホールドアンドヘルスケアリミテッド

2017-11-02 Publication of JP2017197519A publication Critical patent/JP2017197519A/ja

2021-10-20 Priority to JP2021171740A priority Critical patent/JP2022009308A/ja

2021-11-10 Application granted granted Critical

2021-11-10 Publication of JP6966206B2 publication Critical patent/JP6966206B2/ja

Status Active legal-status Critical Current

2037-03-23 Anticipated expiration legal-status Critical

Links

239000000203 mixture Substances 0.000 title claims description 87
206010027304 Menopausal symptoms Diseases 0.000 title claims description 66
208000001132 Osteoporosis Diseases 0.000 title claims description 39
239000000284 extract Substances 0.000 claims description 167
235000013305 food Nutrition 0.000 claims description 47
244000046146 Pueraria lobata Species 0.000 claims description 43
235000010575 Pueraria lobata Nutrition 0.000 claims description 43
239000010227 chenpi Substances 0.000 claims description 33
239000010903 husk Substances 0.000 claims description 28
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 21
239000002537 cosmetic Substances 0.000 claims description 21
230000036541 health Effects 0.000 claims description 20
239000003814 drug Substances 0.000 claims description 19
238000000605 extraction Methods 0.000 claims description 17
235000013376 functional food Nutrition 0.000 claims description 16
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
239000008194 pharmaceutical composition Substances 0.000 claims description 15
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 14
229940079593 drug Drugs 0.000 claims description 14
239000002904 solvent Substances 0.000 claims description 14
230000002265 prevention Effects 0.000 claims description 12
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 11
235000000404 Poncirus trifoliata Nutrition 0.000 claims description 10
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
230000035900 sweating Effects 0.000 claims description 7
208000002173 dizziness Diseases 0.000 claims description 6
206010016256 fatigue Diseases 0.000 claims description 6
239000000825 pharmaceutical preparation Substances 0.000 claims description 6
208000006820 Arthralgia Diseases 0.000 claims description 5
206010019233 Headaches Diseases 0.000 claims description 5
208000008454 Hyperhidrosis Diseases 0.000 claims description 5
208000000112 Myalgia Diseases 0.000 claims description 5
206010029216 Nervousness Diseases 0.000 claims description 5
125000004432 carbon atom Chemical group C* 0.000 claims description 5
231100000869 headache Toxicity 0.000 claims description 5
206010047791 Vulvovaginal dryness Diseases 0.000 claims description 4
229940127557 pharmaceutical product Drugs 0.000 claims description 4
208000013465 muscle pain Diseases 0.000 claims description 3
235000013871 bee wax Nutrition 0.000 claims description 2
239000012166 beeswax Substances 0.000 claims description 2
229940092738 beeswax Drugs 0.000 claims description 2
GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 2
235000012424 soybean oil Nutrition 0.000 claims description 2
239000003549 soybean oil Substances 0.000 claims description 2
244000202052 Poncirus trifoliata Species 0.000 claims 7
206010016825 Flushing Diseases 0.000 claims 3
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims 1
229940067606 lecithin Drugs 0.000 claims 1
235000010445 lecithin Nutrition 0.000 claims 1
239000000787 lecithin Substances 0.000 claims 1
229960001295 tocopherol Drugs 0.000 claims 1
229930003799 tocopherol Natural products 0.000 claims 1
235000010384 tocopherol Nutrition 0.000 claims 1
239000011732 tocopherol Substances 0.000 claims 1
GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims 1
210000004027 cell Anatomy 0.000 description 36
230000000694 effects Effects 0.000 description 35
238000000034 method Methods 0.000 description 29
241000207199 Citrus Species 0.000 description 27
235000020971 citrus fruits Nutrition 0.000 description 26
-1 etc.) Substances 0.000 description 26
235000013361 beverage Nutrition 0.000 description 21
239000006071 cream Substances 0.000 description 16
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
239000004480 active ingredient Substances 0.000 description 15
238000004519 manufacturing process Methods 0.000 description 15
239000000047 product Substances 0.000 description 15
239000004615 ingredient Substances 0.000 description 13
239000006210 lotion Substances 0.000 description 13
BFBPISPWJZMWJN-UHFFFAOYSA-N methyl 2-[(7-hydroxy-3,7-dimethyloctylidene)amino]benzoate Chemical compound COC(=O)C1=CC=CC=C1N=CCC(C)CCCC(C)(C)O BFBPISPWJZMWJN-UHFFFAOYSA-N 0.000 description 13
239000000843 powder Substances 0.000 description 13
208000024891 symptom Diseases 0.000 description 13
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
239000002609 medium Substances 0.000 description 12
239000000546 pharmaceutical excipient Substances 0.000 description 12
239000000796 flavoring agent Substances 0.000 description 11
239000002674 ointment Substances 0.000 description 11
210000000963 osteoblast Anatomy 0.000 description 11
230000035755 proliferation Effects 0.000 description 11
235000014113 dietary fatty acids Nutrition 0.000 description 10
201000010099 disease Diseases 0.000 description 10
239000002552 dosage form Substances 0.000 description 10
239000000194 fatty acid Substances 0.000 description 10
229930195729 fatty acid Natural products 0.000 description 10
230000006870 function Effects 0.000 description 10
230000009245 menopause Effects 0.000 description 10
210000002997 osteoclast Anatomy 0.000 description 10
108010087230 Sincalide Proteins 0.000 description 9
238000010609 cell counting kit-8 assay Methods 0.000 description 9
235000013355 food flavoring agent Nutrition 0.000 description 9
239000003921 oil Substances 0.000 description 9
235000019198 oils Nutrition 0.000 description 9
230000008569 process Effects 0.000 description 9
IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 9
230000001737 promoting effect Effects 0.000 description 8
239000002994 raw material Substances 0.000 description 8
239000007901 soft capsule Substances 0.000 description 8
241001465754 Metazoa Species 0.000 description 7
239000002775 capsule Substances 0.000 description 7
239000003085 diluting agent Substances 0.000 description 7
239000000499 gel Substances 0.000 description 7
239000007788 liquid Substances 0.000 description 7
238000002360 preparation method Methods 0.000 description 7
239000003755 preservative agent Substances 0.000 description 7
241000282412 Homo Species 0.000 description 6
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
239000000654 additive Substances 0.000 description 6
238000012258 culturing Methods 0.000 description 6
235000015872 dietary supplement Nutrition 0.000 description 6
239000000839 emulsion Substances 0.000 description 6
235000013373 food additive Nutrition 0.000 description 6
239000002778 food additive Substances 0.000 description 6
239000003205 fragrance Substances 0.000 description 6
235000011187 glycerol Nutrition 0.000 description 6
230000006872 improvement Effects 0.000 description 6
239000000463 material Substances 0.000 description 6
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
239000013642 negative control Substances 0.000 description 6
239000013641 positive control Substances 0.000 description 6
LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 6
VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 5
206010006187 Breast cancer Diseases 0.000 description 5
208000026310 Breast neoplasm Diseases 0.000 description 5
239000003795 chemical substances by application Substances 0.000 description 5
239000003086 colorant Substances 0.000 description 5
230000000052 comparative effect Effects 0.000 description 5
229960005309 estradiol Drugs 0.000 description 5
229930182833 estradiol Natural products 0.000 description 5
238000005194 fractionation Methods 0.000 description 5
229940088597 hormone Drugs 0.000 description 5
239000005556 hormone Substances 0.000 description 5
235000016709 nutrition Nutrition 0.000 description 5
239000000725 suspension Substances 0.000 description 5
230000001225 therapeutic effect Effects 0.000 description 5
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
244000183685 Citrus aurantium Species 0.000 description 4
241000196324 Embryophyta Species 0.000 description 4
241000699670 Mus sp. Species 0.000 description 4
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
238000002835 absorbance Methods 0.000 description 4
150000001298 alcohols Chemical class 0.000 description 4
239000002585 base Substances 0.000 description 4
150000001720 carbohydrates Chemical class 0.000 description 4
235000014633 carbohydrates Nutrition 0.000 description 4
239000011651 chromium Substances 0.000 description 4
235000013399 edible fruits Nutrition 0.000 description 4
239000003995 emulsifying agent Substances 0.000 description 4
239000000686 essence Substances 0.000 description 4
238000011156 evaluation Methods 0.000 description 4
150000004665 fatty acids Chemical class 0.000 description 4
239000006260 foam Substances 0.000 description 4
BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
239000012071 phase Substances 0.000 description 4
239000006187 pill Substances 0.000 description 4
150000003839 salts Chemical class 0.000 description 4
239000007787 solid Substances 0.000 description 4
239000000243 solution Substances 0.000 description 4
239000004094 surface-active agent Substances 0.000 description 4
239000003826 tablet Substances 0.000 description 4
239000002562 thickening agent Substances 0.000 description 4
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
235000007716 Citrus aurantium Nutrition 0.000 description 3
235000016840 Citrus aurantium var. amara Nutrition 0.000 description 3
241001522083 Citrus trifoliata Species 0.000 description 3
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
206010013786 Dry skin Diseases 0.000 description 3
239000004278 EU approved seasoning Substances 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
208000002193 Pain Diseases 0.000 description 3
235000010443 alginic acid Nutrition 0.000 description 3
229920000615 alginic acid Polymers 0.000 description 3
239000003963 antioxidant agent Substances 0.000 description 3
235000006708 antioxidants Nutrition 0.000 description 3
230000008901 benefit Effects 0.000 description 3
230000001164 bioregulatory effect Effects 0.000 description 3
239000011575 calcium Substances 0.000 description 3
239000000969 carrier Substances 0.000 description 3
239000003153 chemical reaction reagent Substances 0.000 description 3
230000007423 decrease Effects 0.000 description 3
238000002651 drug therapy Methods 0.000 description 3
230000037336 dry skin Effects 0.000 description 3
229940011871 estrogen Drugs 0.000 description 3
239000000262 estrogen Substances 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
239000003925 fat Substances 0.000 description 3
150000002191 fatty alcohols Chemical class 0.000 description 3
230000037406 food intake Effects 0.000 description 3
235000011194 food seasoning agent Nutrition 0.000 description 3
235000020510 functional beverage Nutrition 0.000 description 3
239000008187 granular material Substances 0.000 description 3
230000009422 growth inhibiting effect Effects 0.000 description 3
238000001794 hormone therapy Methods 0.000 description 3
230000007246 mechanism Effects 0.000 description 3
238000002156 mixing Methods 0.000 description 3
235000015097 nutrients Nutrition 0.000 description 3
230000004072 osteoblast differentiation Effects 0.000 description 3
239000006072 paste Substances 0.000 description 3
230000003449 preventive effect Effects 0.000 description 3
239000008213 purified water Substances 0.000 description 3
239000000344 soap Substances 0.000 description 3
235000010288 sodium nitrite Nutrition 0.000 description 3
235000010356 sorbitol Nutrition 0.000 description 3
239000000600 sorbitol Substances 0.000 description 3
229960002920 sorbitol Drugs 0.000 description 3
244000240100 sour orange Species 0.000 description 3
239000007921 spray Substances 0.000 description 3
239000003381 stabilizer Substances 0.000 description 3
150000005846 sugar alcohols Chemical class 0.000 description 3
239000006188 syrup Substances 0.000 description 3
235000020357 syrup Nutrition 0.000 description 3
210000001519 tissue Anatomy 0.000 description 3
235000013343 vitamin Nutrition 0.000 description 3
239000011782 vitamin Substances 0.000 description 3
229940088594 vitamin Drugs 0.000 description 3
229930003231 vitamin Natural products 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 2
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
208000019901 Anxiety disease Diseases 0.000 description 2
244000105624 Arachis hypogaea Species 0.000 description 2
244000003034 Arancio amaro Species 0.000 description 2
206010003694 Atrophy Diseases 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
241000700198 Cavia Species 0.000 description 2
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
235000000228 Citrus myrtifolia Nutrition 0.000 description 2
241001561395 Citrus natsudaidai Species 0.000 description 2
235000016646 Citrus taiwanica Nutrition 0.000 description 2
244000060011 Cocos nucifera Species 0.000 description 2
235000013162 Cocos nucifera Nutrition 0.000 description 2
239000004375 Dextrin Substances 0.000 description 2
229920001353 Dextrin Polymers 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 2
239000006145 Eagle's minimal essential medium Substances 0.000 description 2
239000004386 Erythritol Substances 0.000 description 2
UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
108010010803 Gelatin Proteins 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
206010020772 Hypertension Diseases 0.000 description 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
241000124008 Mammalia Species 0.000 description 2
208000026139 Memory disease Diseases 0.000 description 2
244000294411 Mirabilis expansa Species 0.000 description 2
235000015429 Mirabilis expansa Nutrition 0.000 description 2
206010033557 Palpitations Diseases 0.000 description 2
229920002472 Starch Polymers 0.000 description 2
229930182558 Sterol Natural products 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
206010046914 Vaginal infection Diseases 0.000 description 2
201000008100 Vaginitis Diseases 0.000 description 2
TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
230000009471 action Effects 0.000 description 2
230000000996 additive effect Effects 0.000 description 2
230000032683 aging Effects 0.000 description 2
239000000783 alginic acid Substances 0.000 description 2
229960001126 alginic acid Drugs 0.000 description 2
150000004781 alginic acids Chemical class 0.000 description 2
230000036506 anxiety Effects 0.000 description 2
239000008346 aqueous phase Substances 0.000 description 2
239000012131 assay buffer Substances 0.000 description 2
230000037444 atrophy Effects 0.000 description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
229910052791 calcium Inorganic materials 0.000 description 2
235000001465 calcium Nutrition 0.000 description 2
229910000019 calcium carbonate Inorganic materials 0.000 description 2
229960000541 cetyl alcohol Drugs 0.000 description 2
235000013351 cheese Nutrition 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
210000000038 chest Anatomy 0.000 description 2
229910052804 chromium Inorganic materials 0.000 description 2
239000000084 colloidal system Substances 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
235000009508 confectionery Nutrition 0.000 description 2
239000010949 copper Substances 0.000 description 2
239000000287 crude extract Substances 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
239000003599 detergent Substances 0.000 description 2
235000019425 dextrin Nutrition 0.000 description 2
235000005911 diet Nutrition 0.000 description 2
230000004069 differentiation Effects 0.000 description 2
230000006806 disease prevention Effects 0.000 description 2
208000035475 disorder Diseases 0.000 description 2
239000003937 drug carrier Substances 0.000 description 2
238000001035 drying Methods 0.000 description 2
239000003792 electrolyte Substances 0.000 description 2
239000003623 enhancer Substances 0.000 description 2
UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
235000019414 erythritol Nutrition 0.000 description 2
229940009714 erythritol Drugs 0.000 description 2
150000002148 esters Chemical class 0.000 description 2
102000015694 estrogen receptors Human genes 0.000 description 2
108010038795 estrogen receptors Proteins 0.000 description 2
230000001815 facial effect Effects 0.000 description 2
238000001914 filtration Methods 0.000 description 2
235000019634 flavors Nutrition 0.000 description 2
238000011010 flushing procedure Methods 0.000 description 2
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
235000003599 food sweetener Nutrition 0.000 description 2
235000015203 fruit juice Nutrition 0.000 description 2
239000008273 gelatin Substances 0.000 description 2
229920000159 gelatin Polymers 0.000 description 2
235000019322 gelatine Nutrition 0.000 description 2
235000011852 gelatine desserts Nutrition 0.000 description 2
229960001031 glucose Drugs 0.000 description 2
YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 2
UHUSDOQQWJGJQS-UHFFFAOYSA-N glycerol 1,2-dioctadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCCCC UHUSDOQQWJGJQS-UHFFFAOYSA-N 0.000 description 2
SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 2
235000013402 health food Nutrition 0.000 description 2
IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
229910052500 inorganic mineral Inorganic materials 0.000 description 2
235000021109 kimchi Nutrition 0.000 description 2
239000008101 lactose Substances 0.000 description 2
239000000314 lubricant Substances 0.000 description 2
239000011777 magnesium Substances 0.000 description 2
235000019359 magnesium stearate Nutrition 0.000 description 2
239000011572 manganese Substances 0.000 description 2
238000005259 measurement Methods 0.000 description 2
HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
235000013336 milk Nutrition 0.000 description 2
210000004080 milk Anatomy 0.000 description 2
239000011707 mineral Substances 0.000 description 2
235000010755 mineral Nutrition 0.000 description 2
235000013536 miso Nutrition 0.000 description 2
235000013923 monosodium glutamate Nutrition 0.000 description 2
GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
229930014626 natural product Natural products 0.000 description 2
150000007524 organic acids Chemical class 0.000 description 2
235000005985 organic acids Nutrition 0.000 description 2
239000003960 organic solvent Substances 0.000 description 2
239000012188 paraffin wax Substances 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
235000020232 peanut Nutrition 0.000 description 2
239000000049 pigment Substances 0.000 description 2
QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
229960003415 propylparaben Drugs 0.000 description 2
230000001681 protective effect Effects 0.000 description 2
HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
238000011084 recovery Methods 0.000 description 2
230000033764 rhythmic process Effects 0.000 description 2
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
230000028327 secretion Effects 0.000 description 2
208000019116 sleep disease Diseases 0.000 description 2
235000014214 soft drink Nutrition 0.000 description 2
235000020712 soy bean extract Nutrition 0.000 description 2
239000008107 starch Substances 0.000 description 2
235000019698 starch Nutrition 0.000 description 2
150000003432 sterols Chemical class 0.000 description 2
235000003702 sterols Nutrition 0.000 description 2
239000000126 substance Substances 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
230000000475 sunscreen effect Effects 0.000 description 2
239000000516 sunscreening agent Substances 0.000 description 2
239000003765 sweetening agent Substances 0.000 description 2
239000000454 talc Substances 0.000 description 2
229910052623 talc Inorganic materials 0.000 description 2
229940033134 talc Drugs 0.000 description 2
235000012222 talc Nutrition 0.000 description 2
235000013616 tea Nutrition 0.000 description 2
229940124597 therapeutic agent Drugs 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
230000000699 topical effect Effects 0.000 description 2
210000001215 vagina Anatomy 0.000 description 2
239000000080 wetting agent Substances 0.000 description 2
239000000811 xylitol Substances 0.000 description 2
235000010447 xylitol Nutrition 0.000 description 2
229960002675 xylitol Drugs 0.000 description 2
HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
238000008940 Alkaline Phosphatase assay kit Methods 0.000 description 1
208000000044 Amnesia Diseases 0.000 description 1
235000017060 Arachis glabrata Nutrition 0.000 description 1
235000010777 Arachis hypogaea Nutrition 0.000 description 1
235000018262 Arachis monticola Nutrition 0.000 description 1
241000229175 Calotes Species 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
208000004652 Cardiovascular Abnormalities Diseases 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
208000017667 Chronic Disease Diseases 0.000 description 1
241001481058 Citrus canaliculata Species 0.000 description 1
241001337999 Citrus iyo Species 0.000 description 1
241001001781 Citrus karna Species 0.000 description 1
241001573186 Citrus keraji Species 0.000 description 1
240000003791 Citrus myrtifolia Species 0.000 description 1
241000675139 Citrus pseudogulgul Species 0.000 description 1
241000694496 Citrus reshni Species 0.000 description 1
241001672694 Citrus reticulata Species 0.000 description 1
241000675136 Citrus sulcata Species 0.000 description 1
244000195654 Citrus taiwanica Species 0.000 description 1
241000555678 Citrus unshiu Species 0.000 description 1
DBPRUZCKPFOVDV-UHFFFAOYSA-N Clorprenaline hydrochloride Chemical compound O.Cl.CC(C)NCC(O)C1=CC=CC=C1Cl DBPRUZCKPFOVDV-UHFFFAOYSA-N 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
229920000858 Cyclodextrin Polymers 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
206010012289 Dementia Diseases 0.000 description 1
208000004483 Dyspareunia Diseases 0.000 description 1
241000283086 Equidae Species 0.000 description 1
IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical class C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
239000001512 FEMA 4601 Substances 0.000 description 1
241000220485 Fabaceae Species 0.000 description 1
240000008620 Fagopyrum esculentum Species 0.000 description 1
235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
241000628997 Flos Species 0.000 description 1
206010017062 Formication Diseases 0.000 description 1
229930091371 Fructose Natural products 0.000 description 1
239000005715 Fructose Substances 0.000 description 1
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
241000287828 Gallus gallus Species 0.000 description 1
208000018522 Gastrointestinal disease Diseases 0.000 description 1
206010060891 General symptom Diseases 0.000 description 1
239000004378 Glycyrrhizin Substances 0.000 description 1
229920000084 Gum arabic Polymers 0.000 description 1
206010060800 Hot flush Diseases 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
206010022998 Irritability Diseases 0.000 description 1
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
229920000168 Microcrystalline cellulose Polymers 0.000 description 1
229920000881 Modified starch Polymers 0.000 description 1
239000004368 Modified starch Substances 0.000 description 1
239000004909 Moisturizer Substances 0.000 description 1
OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
206010028813 Nausea Diseases 0.000 description 1
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
240000007594 Oryza sativa Species 0.000 description 1
235000007164 Oryza sativa Nutrition 0.000 description 1
235000021314 Palmitic acid Nutrition 0.000 description 1
229920002230 Pectic acid Polymers 0.000 description 1
241000286209 Phasianidae Species 0.000 description 1
206010036018 Pollakiuria Diseases 0.000 description 1
229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
229920001214 Polysorbate 60 Polymers 0.000 description 1
208000002500 Primary Ovarian Insufficiency Diseases 0.000 description 1
HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
241001093501 Rutaceae Species 0.000 description 1
ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 1
WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 1
206010040799 Skin atrophy Diseases 0.000 description 1
208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
239000004288 Sodium dehydroacetate Substances 0.000 description 1
239000005708 Sodium hypochlorite Substances 0.000 description 1
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
241000269808 Sparus Species 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
244000228451 Stevia rebaudiana Species 0.000 description 1
208000006011 Stroke Diseases 0.000 description 1
241000282887 Suidae Species 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
206010071018 Urogenital atrophy Diseases 0.000 description 1
208000002495 Uterine Neoplasms Diseases 0.000 description 1
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
206010047700 Vomiting Diseases 0.000 description 1
FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 1
LEMJDBDGPTVGML-UHFFFAOYSA-N [K].ON=O Chemical compound [K].ON=O LEMJDBDGPTVGML-UHFFFAOYSA-N 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
235000010489 acacia gum Nutrition 0.000 description 1
239000000205 acacia gum Substances 0.000 description 1
239000002386 air freshener Substances 0.000 description 1
229940072056 alginate Drugs 0.000 description 1
229910052783 alkali metal Inorganic materials 0.000 description 1
229940024606 amino acid Drugs 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
239000003945 anionic surfactant Substances 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
230000003110 anti-inflammatory effect Effects 0.000 description 1
230000003078 antioxidant effect Effects 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
239000003125 aqueous solvent Substances 0.000 description 1
238000003556 assay Methods 0.000 description 1
239000003212 astringent agent Substances 0.000 description 1
235000008452 baby food Nutrition 0.000 description 1
239000003899 bactericide agent Substances 0.000 description 1
235000013527 bean curd Nutrition 0.000 description 1
GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000008512 biological response Effects 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
239000007844 bleaching agent Substances 0.000 description 1
230000036760 body temperature Effects 0.000 description 1
230000037396 body weight Effects 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
239000004067 bulking agent Substances 0.000 description 1
239000002034 butanolic fraction Substances 0.000 description 1
CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
244000309466 calf Species 0.000 description 1
150000004649 carbonic acid derivatives Chemical class 0.000 description 1
238000010000 carbonizing Methods 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
230000003833 cell viability Effects 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
235000010980 cellulose Nutrition 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
230000008859 change Effects 0.000 description 1
239000003610 charcoal Substances 0.000 description 1
235000013330 chicken meat Nutrition 0.000 description 1
239000002036 chloroform fraction Substances 0.000 description 1
235000019219 chocolate Nutrition 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
239000012459 cleaning agent Substances 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
230000001143 conditioned effect Effects 0.000 description 1
239000012050 conventional carrier Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000008406 cosmetic ingredient Substances 0.000 description 1
210000003792 cranial nerve Anatomy 0.000 description 1
239000012043 crude product Substances 0.000 description 1
235000015140 cultured milk Nutrition 0.000 description 1
229940109275 cyclamate Drugs 0.000 description 1
HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
201000003146 cystitis Diseases 0.000 description 1
235000013365 dairy product Nutrition 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
239000000645 desinfectant Substances 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
230000037213 diet Effects 0.000 description 1
230000000378 dietary effect Effects 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
150000002016 disaccharides Chemical class 0.000 description 1
PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
238000010410 dusting Methods 0.000 description 1
201000006549 dyspepsia Diseases 0.000 description 1
230000002526 effect on cardiovascular system Effects 0.000 description 1
HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
239000000469 ethanolic extract Substances 0.000 description 1
239000002038 ethyl acetate fraction Substances 0.000 description 1
230000029142 excretion Effects 0.000 description 1
238000009207 exercise therapy Methods 0.000 description 1
235000019985 fermented beverage Nutrition 0.000 description 1
230000035558 fertility Effects 0.000 description 1
239000000835 fiber Substances 0.000 description 1
239000000945 filler Substances 0.000 description 1
229930003949 flavanone Natural products 0.000 description 1
150000002207 flavanone derivatives Chemical class 0.000 description 1
235000011981 flavanones Nutrition 0.000 description 1
229930003935 flavonoid Natural products 0.000 description 1
150000002215 flavonoids Chemical class 0.000 description 1
235000017173 flavonoids Nutrition 0.000 description 1
229960000304 folic acid Drugs 0.000 description 1
235000019152 folic acid Nutrition 0.000 description 1
239000011724 folic acid Substances 0.000 description 1
235000012041 food component Nutrition 0.000 description 1
239000005417 food ingredient Substances 0.000 description 1
238000009472 formulation Methods 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
235000012055 fruits and vegetables Nutrition 0.000 description 1
208000020694 gallbladder disease Diseases 0.000 description 1
238000012812 general test Methods 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
239000008103 glucose Substances 0.000 description 1
239000003292 glue Substances 0.000 description 1
LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
229960004949 glycyrrhizic acid Drugs 0.000 description 1
235000019410 glycyrrhizin Nutrition 0.000 description 1
LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
239000004519 grease Substances 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
210000004209 hair Anatomy 0.000 description 1
208000019622 heart disease Diseases 0.000 description 1
UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
239000002044 hexane fraction Substances 0.000 description 1
238000002657 hormone replacement therapy Methods 0.000 description 1
239000012535 impurity Substances 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
230000000749 insecticidal effect Effects 0.000 description 1
206010022437 insomnia Diseases 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
235000008696 isoflavones Nutrition 0.000 description 1
150000002596 lactones Chemical class 0.000 description 1
229960001375 lactose Drugs 0.000 description 1
235000019388 lanolin Nutrition 0.000 description 1
235000021374 legumes Nutrition 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
229940057995 liquid paraffin Drugs 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
230000007774 longterm Effects 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
229940057948 magnesium stearate Drugs 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
229910052748 manganese Inorganic materials 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
229960001855 mannitol Drugs 0.000 description 1
235000013622 meat product Nutrition 0.000 description 1
230000007721 medicinal effect Effects 0.000 description 1
230000006984 memory degeneration Effects 0.000 description 1
206010027175 memory impairment Diseases 0.000 description 1
208000023060 memory loss Diseases 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
235000010981 methylcellulose Nutrition 0.000 description 1
LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
235000019813 microcrystalline cellulose Nutrition 0.000 description 1
239000008108 microcrystalline cellulose Substances 0.000 description 1
229940016286 microcrystalline cellulose Drugs 0.000 description 1
230000027939 micturition Effects 0.000 description 1
239000008267 milk Substances 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
235000010446 mineral oil Nutrition 0.000 description 1
229940042472 mineral oil Drugs 0.000 description 1
235000019426 modified starch Nutrition 0.000 description 1
230000001333 moisturizer Effects 0.000 description 1
230000003020 moisturizing effect Effects 0.000 description 1
150000002772 monosaccharides Chemical class 0.000 description 1
LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
210000002346 musculoskeletal system Anatomy 0.000 description 1
WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
239000005445 natural material Substances 0.000 description 1
230000008693 nausea Effects 0.000 description 1
229960003512 nicotinic acid Drugs 0.000 description 1
235000001968 nicotinic acid Nutrition 0.000 description 1
239000011664 nicotinic acid Substances 0.000 description 1
231100001083 no cytotoxicity Toxicity 0.000 description 1
231100000957 no side effect Toxicity 0.000 description 1
230000000422 nocturnal effect Effects 0.000 description 1
239000002736 nonionic surfactant Substances 0.000 description 1
235000012149 noodles Nutrition 0.000 description 1
238000010899 nucleation Methods 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
229940049964 oleate Drugs 0.000 description 1
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
230000011164 ossification Effects 0.000 description 1
230000002611 ovarian Effects 0.000 description 1
210000001672 ovary Anatomy 0.000 description 1
229940055726 pantothenic acid Drugs 0.000 description 1
235000019161 pantothenic acid Nutrition 0.000 description 1
239000011713 pantothenic acid Substances 0.000 description 1
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
208000035824 paresthesia Diseases 0.000 description 1
235000015927 pasta Nutrition 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
229920003175 pectinic acid Polymers 0.000 description 1
239000002304 perfume Substances 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
239000003075 phytoestrogen Substances 0.000 description 1
235000021110 pickles Nutrition 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
239000010318 polygalacturonic acid Substances 0.000 description 1
229920000223 polyglycerol Polymers 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
150000004804 polysaccharides Chemical class 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
239000004302 potassium sorbate Substances 0.000 description 1
235000010241 potassium sorbate Nutrition 0.000 description 1
229940069338 potassium sorbate Drugs 0.000 description 1
239000002243 precursor Substances 0.000 description 1
206010036601 premature menopause Diseases 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
235000020991 processed meat Nutrition 0.000 description 1
230000002062 proliferating effect Effects 0.000 description 1
230000000069 prophylactic effect Effects 0.000 description 1
235000013772 propylene glycol Nutrition 0.000 description 1
239000012264 purified product Substances 0.000 description 1
238000010791 quenching Methods 0.000 description 1
230000000171 quenching effect Effects 0.000 description 1
235000019203 rebaudioside A Nutrition 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
235000021067 refined food Nutrition 0.000 description 1
238000010992 reflux Methods 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
108091008020 response regulators Proteins 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
229940081974 saccharin Drugs 0.000 description 1
235000019204 saccharin Nutrition 0.000 description 1
239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
229960004889 salicylic acid Drugs 0.000 description 1
235000015067 sauces Nutrition 0.000 description 1
HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
239000008299 semisolid dosage form Substances 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
230000001568 sexual effect Effects 0.000 description 1
239000002453 shampoo Substances 0.000 description 1
239000002884 skin cream Substances 0.000 description 1
230000000391 smoking effect Effects 0.000 description 1
235000011888 snacks Nutrition 0.000 description 1
WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
235000010234 sodium benzoate Nutrition 0.000 description 1
239000004299 sodium benzoate Substances 0.000 description 1
229960003885 sodium benzoate Drugs 0.000 description 1
229940080236 sodium cetyl sulfate Drugs 0.000 description 1
235000019259 sodium dehydroacetate Nutrition 0.000 description 1
229940079839 sodium dehydroacetate Drugs 0.000 description 1
229940073490 sodium glutamate Drugs 0.000 description 1
SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
235000019333 sodium laurylsulphate Nutrition 0.000 description 1
DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
GGHPAKFFUZUEKL-UHFFFAOYSA-M sodium;hexadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCOS([O-])(=O)=O GGHPAKFFUZUEKL-UHFFFAOYSA-M 0.000 description 1
NWZBFJYXRGSRGD-UHFFFAOYSA-M sodium;octadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOS([O-])(=O)=O NWZBFJYXRGSRGD-UHFFFAOYSA-M 0.000 description 1
229940057429 sorbitan isostearate Drugs 0.000 description 1
235000014347 soups Nutrition 0.000 description 1
235000013322 soy milk Nutrition 0.000 description 1
235000013555 soy sauce Nutrition 0.000 description 1
229940083466 soybean lecithin Drugs 0.000 description 1
235000013599 spices Nutrition 0.000 description 1
230000003393 splenic effect Effects 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
238000003756 stirring Methods 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000000758 substrate Substances 0.000 description 1
229960004793 sucrose Drugs 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
239000000375 suspending agent Substances 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
230000008961 swelling Effects 0.000 description 1
JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
230000035922 thirst Effects 0.000 description 1
229960000984 tocofersolan Drugs 0.000 description 1
AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
239000000606 toothpaste Substances 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
238000002137 ultrasound extraction Methods 0.000 description 1
230000002485 urinary effect Effects 0.000 description 1
210000001635 urinary tract Anatomy 0.000 description 1
210000002229 urogenital system Anatomy 0.000 description 1
206010046766 uterine cancer Diseases 0.000 description 1
238000003828 vacuum filtration Methods 0.000 description 1
239000004474 valine Substances 0.000 description 1
MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
235000012141 vanillin Nutrition 0.000 description 1
230000002792 vascular Effects 0.000 description 1
230000001457 vasomotor Effects 0.000 description 1
235000013311 vegetables Nutrition 0.000 description 1
235000019155 vitamin A Nutrition 0.000 description 1
239000011719 vitamin A Substances 0.000 description 1
150000003722 vitamin derivatives Chemical class 0.000 description 1
230000008673 vomiting Effects 0.000 description 1
238000003809 water extraction Methods 0.000 description 1
239000001993 wax Substances 0.000 description 1
230000005186 women's health Effects 0.000 description 1
239000002076 α-tocopherol Substances 0.000 description 1
235000004835 α-tocopherol Nutrition 0.000 description 1

Images

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

Health & Medical Sciences (AREA)
Natural Medicines & Medicinal Plants (AREA)
Life Sciences & Earth Sciences (AREA)
Botany (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Mycology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Alternative & Traditional Medicine (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medical Informatics (AREA)
Veterinary Medicine (AREA)
Nutrition Science (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Medicines Containing Plant Substances (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

JP2017057171A 2016-04-25 2017-03-23 更年期症状又は骨粗鬆症改善用組成物 Active JP6966206B2 (ja)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
JP2021171740A JP2022009308A (ja)	2016-04-25	2021-10-20	更年期症状又は骨粗鬆症改善用組成物

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
KR1020160050096A KR102204346B1 (ko)	2016-04-25	2016-04-25	갱년기 증상 또는 골다공증 개선용 조성물
KR10-2016-0050096		2016-04-25

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2021171740A Division JP2022009308A (ja)	2016-04-25	2021-10-20	更年期症状又は骨粗鬆症改善用組成物

Publications (2)

Publication Number	Publication Date
JP2017197519A JP2017197519A (ja)	2017-11-02
JP6966206B2 true JP6966206B2 (ja)	2021-11-10

Family

ID=60150872

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
JP2017057171A Active JP6966206B2 (ja)	2016-04-25	2017-03-23	更年期症状又は骨粗鬆症改善用組成物
JP2021171740A Pending JP2022009308A (ja)	2016-04-25	2021-10-20	更年期症状又は骨粗鬆症改善用組成物

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
JP2021171740A Pending JP2022009308A (ja)	2016-04-25	2021-10-20	更年期症状又は骨粗鬆症改善用組成物

Country Status (3)

Country	Link
JP (2)	JP6966206B2 (ko)
KR (1)	KR102204346B1 (ko)
CN (1)	CN107303006A (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2022009308A (ja) *	2016-04-25	2022-01-14	エルジーハウスホールドアンドヘルスケアリミテッド	更年期症状又は骨粗鬆症改善用組成物

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR102178967B1 (ko) *	2018-10-02	2020-11-13	주식회사 엘지생활건강	갈화 발효 추출물을 포함하는 갱년기 증상의 예방 또는 치료용 조성물
KR102324869B1 (ko) *	2018-10-02	2021-11-09	주식회사 엘지생활건강	분갈 추출물 또는 이로부터 유래된 화합물을 포함하는 피부 개선용 조성물
KR20220042229A (ko)	2019-09-12	2022-04-04	가부시키가이샤 도요 신야쿠	갈화 건조 분말 및 갈화 건조 분말을 함유하는 식품

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1205886A (zh) *	1997-07-17	1999-01-27	柳永明	有机钙壮骨粉
US20020071976A1 (en)	2000-11-03	2002-06-13	Edlund David J.	Sulfur-absorbent bed and fuel processing assembly incorporating the same
CN1164297C (zh) *	2001-04-23	2004-09-01	王维林	葛根、葛根黄酮以及葛根素用于制备预防和治疗骨质疏松症的药物的用途
KR100586813B1 (ko) *	2001-10-10	2006-06-08	한국 한의학 연구원	혼합 생약재 추출물 및 이를 포함하는 골다공증 예방 또는 치료용 건강식품
CN1265725C (zh) *	2003-11-13	2006-07-26	上海奥医高科技实业有限公司	具有延缓衰老和增加骨密度功能的保健食品
WO2005105125A1 (ja) *	2004-03-04	2005-11-10	Asahi Breweries, Ltd.	骨粗鬆症予防または治療剤
KR100613447B1 (ko)	2004-10-07	2006-08-21	주식회사 하이닉스반도체	데이터 래치회로 및 이를 이용한 반도체 장치
KR100851783B1 (ko) *	2007-04-16	2008-08-13	경희대학교 산학협력단	Ｂｈｈ１７ 복합생약추출물을 유효성분으로 함유하는골절 질환의 예방 및 치료용 조성물
KR100872108B1 (ko) *	2007-05-14	2008-12-05	아주대학교산학협력단	지실 추출물을 함유하는 골다공증 예방 또는 치료용 조성물
JP2009126853A (ja) *	2007-11-27	2009-06-11	Tsujido Kagaku Kk	治療剤
CN101239092B (zh) *	2008-03-14	2010-10-20	山东省医学科学院药物研究所	一种葛花异黄酮提取物、其提取方法、药物组合物及其在制药中的应用
CN101716001A (zh) *	2009-12-07	2010-06-02	周文兴	一种解酒护肝饮料及生产方法
CN102580033B (zh) *	2012-03-13	2014-05-07	广西梧州三鹤药业有限公司	治疗皮肤损伤的药物组合物的检测方法
CN103656428A (zh) *	2013-12-11	2014-03-26	青岛友铭辰生物技术有限公司	一种解酒醒酒的中药汤剂
CN104873895A (zh) *	2015-05-26	2015-09-02	李厚建	一种治疗更年期综合症的中药组合物
CN104958607A (zh) *	2015-07-21	2015-10-07	青岛恒波仪器有限公司	一种治疗妇女更年期灼口综合征的中药组合物及方法
KR102204346B1 (ko) *	2016-04-25	2021-01-18	주식회사 엘지생활건강	갱년기 증상 또는 골다공증 개선용 조성물

2016
- 2016-04-25 KR KR1020160050096A patent/KR102204346B1/ko active IP Right Grant
2017
- 2017-03-23 JP JP2017057171A patent/JP6966206B2/ja active Active
- 2017-03-31 CN CN201710207874.8A patent/CN107303006A/zh active Pending
2021
- 2021-10-20 JP JP2021171740A patent/JP2022009308A/ja active Pending

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2022009308A (ja) *	2016-04-25	2022-01-14	エルジーハウスホールドアンドヘルスケアリミテッド	更年期症状又は骨粗鬆症改善用組成物

Also Published As

Publication number	Publication date
JP2022009308A (ja)	2022-01-14
KR102204346B1 (ko)	2021-01-18
JP2017197519A (ja)	2017-11-02
KR20170121532A (ko)	2017-11-02
CN107303006A (zh)	2017-10-31

Publication	Publication Date	Title
JP2022009308A (ja)	2022-01-14	更年期症状又は骨粗鬆症改善用組成物
KR20110004603A (ko)	2011-01-14	폐경기 질환의 치료 또는 예방, 피부 노화 방지, 또는 피부 주름 개선용 회화나무 추출물
KR102511361B1 (ko)	2023-03-20	해당화 추출물을 유효성분으로 포함하는 여성 폐경기 증후군 예방, 개선 또는 치료용 조성물
JP6709783B2 (ja)	2020-06-17	アルパインワームウッド抽出物を含む脱毛防止または育毛促進用組成物
KR102519649B1 (ko)	2023-04-10	캠퍼롤 및 에피카테킨 갈레이드를 포함하는 홍경천 추출물을 포함하는 전립선 관련 질환의 예방 또는 치료용 조성물
KR102275268B1 (ko)	2021-07-09	갱년기 증상 또는 골다공증 개선용 조성물
TW200401780A (en)	2004-02-01	Novel derivative of flavone C-glycoside and composition containing the same
US10806766B2 (en)	2020-10-20	Method for treating, preventing, or alleviating osteoporosis
JP2024050702A (ja)	2024-04-10	エンテロコッカス・フェカーリスを有効成分として含有する肥満または肥満から誘導された代謝症候群の予防または治療用の組成物
KR102347819B1 (ko)	2022-01-06	갱년기 증상 또는 골다공증 개선용 조성물
EP3449736B1 (en)	2020-08-19	Composition for relieving menopausal symptom or osteoporosis
JP2004323439A (ja)	2004-11-18	血液粘性改善用組成物
KR102068198B1 (ko)	2020-01-20	털이슬 추출물을 함유하는 여성 폐경기 증후군 예방 또는 치료용 조성물
KR101436213B1 (ko)	2014-09-01	긴잎모시풀 추출물을 포함하는 비만의 예방 또는 치료용 조성물
KR101897720B1 (ko)	2018-09-12	갈색거저리 탈지 분획물을 함유하는 모발 성장 촉진용 조성물
JP5362976B2 (ja)	2013-12-11	血流改善剤
KR102427768B1 (ko)	2022-08-02	배초향 추출물을 함유하는 여성 폐경기 증후군 예방 또는 치료용 조성물
KR102588771B1 (ko)	2023-10-13	불레기말 또는 반질불레기말 추출물을 유효성분으로 포함하는 에스트로겐 감소에 의한 증상 완화 및 개선용 조성물
KR102541649B1 (ko)	2023-06-20	엉겅퀴, 우슬, 칡, 아로니아, 석류, 하수오 및 생강을 포함하는 여성 갱년기 증상의 예방, 치료 또는 개선용 조성물
KR20180120120A (ko)	2018-11-05	마리안 플럼 추출물을 유효성분으로 함유하는 피부 항노화 및 보습용 조성물
KR20170083493A (ko)	2017-07-18	갱년기 증상 개선용 조성물
KR20170133821A (ko)	2017-12-06	안면홍조 또는 골다공증 증상 완화용 조성물
KR20120122404A (ko)	2012-11-07	괄루근 추출물을 포함하는 신장암 치료용 조성물 및 건강 기능성 식품
KR20210013497A (ko)	2021-02-04	새싹귀리 추출물을 포함하는 아토피 피부염 예방 또는 치료용 조성물
KR20170130081A (ko)	2017-11-28	천문동 추출물을 유효성분으로 함유하는 여성 호르몬 조절이상 질환의 예방 및 개선을 위한 조성물

Legal Events

Date	Code	Title	Description
2020-03-19	A621	Written request for application examination	Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200319
2021-05-10	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210510
2021-07-09	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210709
2021-09-10	TRDD	Decision of grant or rejection written
2021-09-21	A01	Written decision to grant a patent or to grant a registration (utility model)	Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210921
2021-10-25	A61	First payment of annual fees (during grant procedure)	Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20211021
2021-10-25	R150	Certificate of patent or registration of utility model	Ref document number: 6966206 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150
2024-10-09	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250

JP6966206B2 - 更年期症状又は骨粗鬆症改善用組成物 - Google Patents

Info

Links

Images

Classifications

Landscapes

Priority Applications (1)

Applications Claiming Priority (2)

Related Child Applications (1)

Publications (2)

Family

ID=60150872

Family Applications (2)

Family Applications After (1)

Country Status (3)

Cited By (1)

Families Citing this family (3)

Family Cites Families (17)

Cited By (1)

Also Published As

Similar Documents

Legal Events